abstract |
Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions as HSL inhibitors for the treatment of diabetes, wherein R 1 ,R 2 , R 3 , C a and C b have the significance given in claim 1. |